NCT01699685 - Swiss studY for the Treatment of COPD Patients With the Free combiNation of indacatERol and GlYcopyrroniumbromide. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions

Chronic Obstructive Pulmonary Disease: COPD

Interventions

DRUG

QAB149

Capsule form in blister packs inhaled with the Novartis Concept 1 SDDPI

DRUG

Placebo

Capsule form in blister packs inhaled with the Novartis Concept 1 SDDPI

DRUG

NVA237

Capsule form in blister packs inhaled with the Novartis Concept 1 SDDPI

Trial Locations (11)

Novartis Investigative Site, Lausanne

Novartis Investigative Site, Bern

Novartis Investigative Site, Bern

Novartis Investigative Site, Crans-Montana

Novartis Investigative Site, Basel

Novartis Investigative Site, Barmelweid

Novartis Investigative Site, Locarno

Novartis Investigative Site, Lugano

Novartis Investigative Site, Faltigberg-Wald

Novartis Investigative Site, Walenstadtberg

Novartis Investigative Site, Sankt Gallen